Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors

Published:2012-01-01 Issue:01 Volume:50 Page:76-78
ISSN:0946-1965
Container-title:Int. Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:CP

Author:

Strumberg Dirk,Schultheis Beate,Traugott Ulrich,Vank Christiane,Santel Ansgar,Keil Oliver,Giese Klaus,Kaufmann Jörg,Drevs Joachim

Publisher

Dustri-Verlgag Dr. Karl Feistle

Subject

Pharmacology (medical),Pharmacology

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions;Oncology and Therapy;2024-05-17

2. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals;Advanced Materials;2023-12-31

3. Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors;Nature Chemical Biology;2023-10-30

4. Research progress on non-protein-targeted drugs for cancer therapy;Journal of Experimental & Clinical Cancer Research;2023-03-14

5. Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors;Pharmaceuticals;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP